• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床实践中类风湿关节炎疾病活动的监测:来自临床试验的贡献。

Monitoring disease activity of rheumatoid arthritis in clinical practice: contributions from clinical trials.

作者信息

Zatarain Ernesto, Strand Vibeke

机构信息

Division of Immunology and Rheumatology at Stanford University School of Medicine, Palo Alto, CA 94035, USA.

出版信息

Nat Clin Pract Rheumatol. 2006 Nov;2(11):611-8. doi: 10.1038/ncprheum0246.

DOI:10.1038/ncprheum0246
PMID:17075600
Abstract

Rheumatoid arthritis is a heterogeneous and progressive autoimmune disease, and patients with this condition show varied responses to treatment. Practical, reliable, individually tailored measures of disease activity and treatment responses are needed. Outcome measures used in randomized, controlled trials, including American College of Rheumatology response criteria and Disease Activity Scores, identify when treatment should be initiated or changed, but can be time consuming and impractical in daily practice. Simplified disease activity indices, abbreviated joint counts and patient-report questionnaires are more-convenient ways to assess therapeutic responses in the clinic. Patient-reported measures of physical function, pain and global disease activity best differentiate the results of active treatment from those of placebo treatment in randomized, controlled trials. Improvements in physical function closely reflect changes in health-related quality of life. Recent trials have demonstrated limited correlations between clinical responses and radiographically demonstrated responses; both should be assessed on a regular basis. It is recommended that three domains be assessed in the clinic for therapeutic responses: patient-reported measures of physical function and/or global disease activity; physician assessment of disease activity; and imaging of the hands and/or feet on a biannual basis. Problematic joints and cervical spine involvement should be followed as clinically indicated. Measures of improvement for individually relevant physical activities need to be defined for each patient.

摘要

类风湿关节炎是一种异质性的进行性自身免疫性疾病,患有这种疾病的患者对治疗表现出不同的反应。需要实用、可靠、个性化定制的疾病活动度和治疗反应评估方法。随机对照试验中使用的疗效指标,包括美国风湿病学会反应标准和疾病活动评分,可确定何时应开始或改变治疗,但在日常实践中可能耗时且不实用。简化疾病活动指数、简化关节计数和患者报告问卷是在临床中评估治疗反应更便捷的方法。在随机对照试验中,患者报告的身体功能、疼痛和整体疾病活动度指标最能区分积极治疗与安慰剂治疗的结果。身体功能的改善密切反映与健康相关的生活质量的变化。最近的试验表明临床反应与影像学显示的反应之间相关性有限;两者均应定期评估。建议在临床中从三个方面评估治疗反应:患者报告的身体功能和/或整体疾病活动度指标;医生对疾病活动度的评估;以及每年两次对手和/或脚进行成像检查。有问题的关节和颈椎受累情况应根据临床指征进行随访。需要为每位患者确定与个体相关的身体活动的改善指标。

相似文献

1
Monitoring disease activity of rheumatoid arthritis in clinical practice: contributions from clinical trials.临床实践中类风湿关节炎疾病活动的监测:来自临床试验的贡献。
Nat Clin Pract Rheumatol. 2006 Nov;2(11):611-8. doi: 10.1038/ncprheum0246.
2
A proposed continuous quality improvement approach to assessment and management of patients with rheumatoid arthritis without formal joint counts, based on quantitative routine assessment of patient index data (RAPID) scores on a multidimensional health assessment questionnaire (MDHAQ).一种基于多维健康评估问卷(MDHAQ)上的患者指数数据定量常规评估(RAPID)评分,对无正式关节计数的类风湿关节炎患者进行评估和管理的拟议持续质量改进方法。
Best Pract Res Clin Rheumatol. 2007 Aug;21(4):789-804. doi: 10.1016/j.berh.2007.02.009.
3
RAPID3, an index to assess and monitor patients with rheumatoid arthritis, without formal joint counts: similar results to DAS28 and CDAI in clinical trials and clinical care.RAPID3,一种用于评估和监测类风湿关节炎患者的指标,无需进行正式的关节计数:在临床试验和临床护理中与 DAS28 和 CDAI 结果相似。
Rheum Dis Clin North Am. 2009 Nov;35(4):773-8, viii. doi: 10.1016/j.rdc.2009.10.008.
4
Time to score quantitative rheumatoid arthritis measures: 28-Joint Count, Disease Activity Score, Health Assessment Questionnaire (HAQ), Multidimensional HAQ (MDHAQ), and Routine Assessment of Patient Index Data (RAPID) scores.类风湿关节炎定量指标的评分时间:28个关节计数、疾病活动评分、健康评估问卷(HAQ)、多维健康评估问卷(MDHAQ)以及患者指数数据常规评估(RAPID)评分。
J Rheumatol. 2008 Apr;35(4):603-9. Epub 2008 Mar 1.
5
Differences in clinical status measures in different ethnic/racial groups with early rheumatoid arthritis: implications for interpretation of clinical trial data.早期类风湿关节炎不同种族/民族群体临床状况指标的差异:对临床试验数据解读的启示
J Rheumatol. 2007 Feb;34(2):311-5.
6
Quantitative measures and indices to assess rheumatoid arthritis in clinical trials and clinical care.在临床试验和临床护理中评估类风湿性关节炎的定量测量方法和指标。
Rheum Dis Clin North Am. 2004 Nov;30(4):725-51, vi. doi: 10.1016/j.rdc.2004.08.001.
7
Limitations of a quantitative swollen and tender joint count to assess and monitor patients with rheumatoid arthritis.采用定量的肿胀和压痛关节计数来评估和监测类风湿关节炎患者的局限性。
Bull NYU Hosp Jt Dis. 2008;66(3):216-23.
8
Monitoring response to therapy in rheumatoid arthritis - perspectives from the clinic.类风湿关节炎治疗反应的监测——临床视角
Bull NYU Hosp Jt Dis. 2009;67(2):236-42.
9
Validation of a simple activity participation measure for rheumatoid arthritis clinical trials.类风湿关节炎临床试验中一种简单活动参与度测量方法的验证
Rheumatology (Oxford). 2009 Feb;48(2):170-5. doi: 10.1093/rheumatology/ken448.
10
The uses of disease activity scoring and the physician global assessment of disease activity for managing rheumatoid arthritis in rheumatology practice.疾病活动评分和医生对疾病活动的整体评估在风湿病学实践中用于管理类风湿关节炎的用途。
J Rheumatol. 2009 May;36(5):925-9. doi: 10.3899/jrheum.081046. Epub 2009 Apr 15.

引用本文的文献

1
Fibrinogen-Like Protein 1 Is a Novel Biomarker for Predicting Disease Activity and Prognosis of Rheumatoid Arthritis.纤维蛋白原样蛋白 1 是预测类风湿关节炎疾病活动度和预后的新型生物标志物。
Front Immunol. 2020 Oct 6;11:579228. doi: 10.3389/fimmu.2020.579228. eCollection 2020.
2
Patient-centered psoriatic arthritis (PsA) activity assessment by Stockerau Activity Score for Psoriatic Arthritis (SASPA).采用银屑病关节炎斯托克劳活动评分(SASPA)进行以患者为中心的银屑病关节炎(PsA)活动评估。
BMC Musculoskelet Disord. 2015 Apr 1;16:73. doi: 10.1186/s12891-015-0512-7.
3
A store-operated calcium channel inhibitor attenuates collagen-induced arthritis.
一种储存性钙通道抑制剂可减轻胶原诱导的关节炎。
Br J Pharmacol. 2015 Jun;172(12):2991-3002. doi: 10.1111/bph.13104. Epub 2015 Mar 27.
4
Imaging as an Outcome Measure in Gout Studies: Report from the OMERACT Gout Working Group.影像学作为痛风研究的结局指标:OMERACT痛风工作组报告
J Rheumatol. 2015 Dec;42(12):2460-4. doi: 10.3899/jrheum.141164. Epub 2015 Feb 1.
5
Effectiveness and Costs of TNF-Alpha Blocker Use for Patients with Rheumatoid Arthritis.肿瘤坏死因子-α阻滞剂用于类风湿关节炎患者的有效性及成本
Am Health Drug Benefits. 2013 Mar;6(2):126-36.
6
Secukinumab treatment in rheumatoid arthritis is associated with incremental benefit in the clinical outcomes and HRQoL improvements that exceed minimally important thresholds.司库奇尤单抗治疗类风湿性关节炎与临床结局的增量获益以及超过最小重要阈值的健康相关生活质量改善相关。
Health Qual Life Outcomes. 2014 Mar 5;12:31. doi: 10.1186/1477-7525-12-31.
7
Development of a multi-biomarker disease activity test for rheumatoid arthritis.类风湿关节炎多生物标志物疾病活动测试的研发。
PLoS One. 2013 Apr 9;8(4):e60635. doi: 10.1371/journal.pone.0060635. Print 2013.
8
A multi-biomarker score measures rheumatoid arthritis disease activity in the BeSt study.多生物标志物评分可衡量 BeSt 研究中的类风湿关节炎疾病活动度。
Rheumatology (Oxford). 2013 Jul;52(7):1202-7. doi: 10.1093/rheumatology/kes362. Epub 2013 Feb 7.
9
Patient's global assessment of disease activity and patient's assessment of general health for rheumatoid arthritis activity assessment: are they equivalent?患者对疾病活动的总体评估和患者对类风湿关节炎活动评估的一般健康状况评估:它们是否等效?
Ann Rheum Dis. 2012 Dec;71(12):1942-9. doi: 10.1136/annrheumdis-2011-201142. Epub 2012 Apr 24.
10
The correlation between increased serum concentrations of interleukin-6 family cytokines and disease activity in rheumatoid arthritis patients.白细胞介素-6 家族细胞因子血清浓度与类风湿关节炎患者疾病活动度的相关性。
Yonsei Med J. 2011 Jan;52(1):113-20. doi: 10.3349/ymj.2011.52.1.113.